A machine learning approach to brain epigenetic analysis reveals kinases associated with Alzheimer's disease.
Source check: Source checked. Not independent scientific confirmation.
Finding: The primary study applies EWASplus machine learning to extrapolate epigenome-wide association signals and reports candidate Alzheimer’s-associated loci/kinases, with targeted bisulfite sequencing for a subset. This supports an association result; it does not establish kinase causality. Organization is unavailable in the deposited bibliographic metadata.
Technology: Machine-learning models for multimodal dementia prediction
Publication: Publication status unspecified in annotation · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- PMC/Nature full Methods/Results: ROS/MAP 717 participants plus three cohorts; targeted sequencing of 559 selected sites from 150 donors, 319 passing QC; 25/38 predicted-positive clusters associated with an AD trait versus 3/10 negative controls; kinase enrichment p=.044.
- Test and result
- The primary study applies EWASplus machine learning to extrapolate epigenome-wide association signals and reports candidate Alzheimer’s-associated loci/kinases, with targeted bisulfite sequencing for a subset. This supports an association result; it does not establish kinase causality.
- Limitation / still unknown
- This supports an association result; it does not establish kinase causality.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8298578/
The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.